GT Biopharma, Inc.

DB:OXIA Stock Report

Market Cap: €3.9m

GT Biopharma, Inc. Company Information

GT Biopharma, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: GT Biopharma, Inc.
  • Ticker: OXIA
  • Exchange: DB
  • Founded: 1965
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$4.142m
  • Listing Market Cap: US$3.887m
  • Shares Outstanding: 1.38m
  • Website: https://www.gtbiopharma.com

Number of Employees

Location

  • GT Biopharma, Inc.
  • 8000 Marina Boulevard
  • Suite 100
  • Brisbane
  • California
  • 94005
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GTBPNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJan 1971
OXIADB (Deutsche Boerse AG)YesCommon StockDEEURJan 1971

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/05/01 12:15
End of Day Share Price 2024/02/02 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.